Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael C Levin

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Archives of Physical Medicine and Rehabilitation|May 18, 2026
Translingual neural stimulation to improve gait and balance in multiple sclerosis: A randomized controlled trialSarah J Donkers, Keith R Lohse, Ganeswara Rao Melam, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|November 9, 2024
Dysfunctional RNA binding protein induced neurodegeneration is attenuated by inhibition of the integrated stress responseJoseph-Patrick W E Clarke, Miranda L Messmer, Jacob Pilon, et al.
Multiple Sclerosis International|July 30, 2021
A Tripartite Knowledge Translation Program: Innovative Patient-Centered Approach to Clinical Research Participation for Individuals with Multiple SclerosisAman Saini, Colleen Cochran, Audrey Zucker-Levin, et al.
Electrophoresis|February 19, 2013
LC-MS/MS identification of the one-carbon cycle metabolites in human plasmaLidia A Gardner, Dominic M Desiderio, Chassidy J Groover, et al.
Journal of Neuroinflammation|July 9, 2016
Antibodies to the RNA-binding protein hnRNP A1 contribute to neurodegeneration in a model of central nervous system autoimmune inflammatory diseaseJoshua N Douglas, Lidia A Gardner, Hannah E Salapa, et al.
Glia|May 3, 2023
Acute intermittent hypoxia alters disease course and promotes CNS repair including resolution of inflammation and remyelination in the experimental autoimmune encephalomyelitis model of MSNataliya Tokarska, Justin M A Naniong, Jayne M Johnston, et al.
Nature Medicine|May 2, 2002
Autoimmunity due to molecular mimicry as a cause of neurological diseaseMichael C Levin, Sang Min Lee, Franck Kalume, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|July 14, 2020
Treatment Optimization in Multiple Sclerosis: Canadian MS Working Group RecommendationsMark S Freedman, Virginia Devonshire, Pierre Duquette, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|June 9, 2025
First-Line Use of Higher-Efficacy Disease-Modifying Therapies in Multiple Sclerosis: Canadian Consensus RecommendationsMark S Freedman, Fraser Clift, Virginia Devonshire, et al.
BMC Sports Science, Medicine & Rehabilitation|December 22, 2023
Task-oriented exercise effects on walking and corticospinal excitability in multiple sclerosis: protocol for a randomized controlled trialZahra Moslemi, Eduardo A Toledo-Aldana, Bruce Baldwin, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Archives of Physical Medicine and Rehabilitation|May 18, 2026
Translingual neural stimulation to improve gait and balance in multiple sclerosis: A randomized controlled trialSarah J Donkers, Keith R Lohse, Ganeswara Rao Melam, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|November 9, 2024
Dysfunctional RNA binding protein induced neurodegeneration is attenuated by inhibition of the integrated stress responseJoseph-Patrick W E Clarke, Miranda L Messmer, Jacob Pilon, et al.
Multiple Sclerosis International|July 30, 2021
A Tripartite Knowledge Translation Program: Innovative Patient-Centered Approach to Clinical Research Participation for Individuals with Multiple SclerosisAman Saini, Colleen Cochran, Audrey Zucker-Levin, et al.
Electrophoresis|February 19, 2013
LC-MS/MS identification of the one-carbon cycle metabolites in human plasmaLidia A Gardner, Dominic M Desiderio, Chassidy J Groover, et al.
Journal of Neuroinflammation|July 9, 2016
Antibodies to the RNA-binding protein hnRNP A1 contribute to neurodegeneration in a model of central nervous system autoimmune inflammatory diseaseJoshua N Douglas, Lidia A Gardner, Hannah E Salapa, et al.
Glia|May 3, 2023
Acute intermittent hypoxia alters disease course and promotes CNS repair including resolution of inflammation and remyelination in the experimental autoimmune encephalomyelitis model of MSNataliya Tokarska, Justin M A Naniong, Jayne M Johnston, et al.
Nature Medicine|May 2, 2002
Autoimmunity due to molecular mimicry as a cause of neurological diseaseMichael C Levin, Sang Min Lee, Franck Kalume, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|July 14, 2020
Treatment Optimization in Multiple Sclerosis: Canadian MS Working Group RecommendationsMark S Freedman, Virginia Devonshire, Pierre Duquette, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|June 9, 2025
First-Line Use of Higher-Efficacy Disease-Modifying Therapies in Multiple Sclerosis: Canadian Consensus RecommendationsMark S Freedman, Fraser Clift, Virginia Devonshire, et al.
BMC Sports Science, Medicine & Rehabilitation|December 22, 2023
Task-oriented exercise effects on walking and corticospinal excitability in multiple sclerosis: protocol for a randomized controlled trialZahra Moslemi, Eduardo A Toledo-Aldana, Bruce Baldwin, et al.
Pageof 7